News Highlights: Top Company News of the Day
July 18 2019 - 11:30AM
Dow Jones News
Morgan Stanley Quarterly Profit Falls 10%
Second-quarter profit fell 10% at Morgan Stanley, the last of
the big U.S. banks to report earnings in a mixed quarter where
trading slowed and Main Street banks carried the day.
Blackstone's Earnings Fall as Private-Equity Portfolio Cools
Blackstone's second-quarter earnings fell from a year earlier as
the value of its private-equity portfolio appreciated less.
Honeywell Posts Higher Profit
Honeywell reported stronger demand and higher organic sales in
its commercial aerospace, defense, process automation and
business-technologies businesses.
UnitedHealth Lifts Profit Targets on Stronger Sales
UnitedHealth Group raised its 2019 earnings targets after
reporting a strong first half of the year, driven by broader sales
growth in premiums, products and services.
Vodafone's Liberty Global Deal Gets EU Nod
The European Union's antitrust authority has cleared Vodafone
Group's acquisition of some assets from Liberty Global, paving the
way for a multibillion-euro deal that is set to reshape the
European telecoms market.
Digital Banking Startup Overcomes Setbacks to Raise $170 Million
A digital bank with operations across Europe which recently
launched in the U.S. has raised another $170 million in its latest
funding round, pushing its valuation to $3.5 billion.
iHeartMedia Returns to Public Markets
The nation's largest radio broadcaster begins trading about 2
1/2 months after emerging from bankruptcy.
Qualcomm Hit by Second Antitrust Fine in Europe
The EU is imposing a $272 million fine on Qualcomm, its second
penalty on the chip maker in 18 months, and its latest move
targeting top U.S. tech companies for breaching antitrust
rules.
Paint Maker PPG Posts Lower Sales on Weak Industrial Demand
PPG said weak demand from industrial clients is hurting sales,
challenging the company's decision to keep its paint and coatings
businesses joined together.
Novartis Sets $700 Million Provision to Settle Bribery Allegations
Swiss drugmaker Novartis set aside $700 million to settle a
long-running lawsuit alleging it treated U.S. doctors to lavish
dinners and other events in return for boosting prescriptions.
(END) Dow Jones Newswires
July 18, 2019 11:15 ET (15:15 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.